Charcot Marie Tooth Disease



Effect of Orthoses and Underfoot Vibration on Balance in Neuropathy


Conditions:   CMT - Charcot-Marie-Tooth Disease;   Peripheral Neuropathy;   Hereditary Peripheral Neuropathy;   CMT1A
Intervention:  
Sponsors:   St George's, University of London;   University College London Hospitals
Not yet recruiting


A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.


Condition:   Charcot-Marie-Tooth Disease
Interventions:   Drug: FLX-787-ODT (orally disintegrating tablet);   Drug: Placebo ODT
Sponsor:   Flex Pharma, Inc.
Not yet recruiting


Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease


Condition:   Charcot-Marie-Tooth Disease
Intervention:   Drug: ACE-083
Sponsor:   Acceleron Pharma, Inc.
Recruiting


Efficacy of Keyhole Approach to Carpal Tunnel Syndrome Under Ambulatory Strategy


Conditions:   Carpal Tunnel Syndrome;   Entrapment Neuropathy
Intervention:   Procedure: keyhole approach
Sponsor:   Ivan Segura Duran
Completed


Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A


Condition:   Charcot-Marie-Tooth Disease, Type IA
Intervention:   Drug: PXT3003
Sponsors:   Pharnext SA;   SynteractHCR;   INC Research
Recruiting


BALTiC Study: A Feasibility Analysis of Home Based BALance Training in People With Charcot-Marie-Tooth Disease


Condition:   Charcot-Marie-Tooth Disease, Type IA
Interventions:   Behavioral: Falls management plus exercise training;   Behavioral: Falls management only
Sponsors:   University College London Hospitals;   Charcot Marie Tooth United Kingdom;   Kingston University
Recruiting


Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)


Condition:   Charcot-Marie-Tooth Disease
Intervention:   Other: No intervention involved
Sponsors:   Sydney Children's Hospitals Network;   University of Iowa Health Care;   Children's Hospital of Philadelphia;   University of Pennsylvania;   University of Rochester;   National Hospital of Neurology and Neurosurgery;   Dubowitz Neuromuscular Centre;   University of Miami;   Besta Neurological Institute;   Johns Hopkins University;   Vanderbilt University;   University of Washington;   Nemours Children's Hospital;   National Institutes of Health - Intramural Branch (Bethesda);   Stanford University;   Cedars-Sinai Medical Center;   Harvard/Massachusetts General Hospital;   University of Michigan;   University of Minnesota - Clinical and Translational Science Institute;   University of Utah;   University of Connecticut;   Universiteit Antwerpen
Recruiting


SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study


Conditions:   Chronic Inflammatory Demyelinating Polyneuropathy;   Peripheral Neuropathy;   Charcot-Marie-Tooth Disease;   Charcot-Marie-Tooth Disease Type 1A;   Charcot-Marie-Tooth Disease, Type IA
Intervention:   Drug: MD1003
Sponsor:   MedDay Pharmaceuticals SA
Recruiting


Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies


Conditions:   Carpal Tunnel Syndrome;   Charcot-Marie-Tooth Disease;   Inherited Peripheral Neuropathy
Intervention:   Other: Web-based survey
Sponsors:   University of South Florida;   National Institute of Neurological Disorders and Stroke (NINDS);   University of Rochester;   University of Iowa
Completed


Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain


Conditions:   Chronic Abdominal Wall Pain;   Abdominal Cutaneous Nerve Entrapment Syndrome
Interventions:   Drug: Triamcinolone;   Other: Placebo;   Drug: Lidocaine
Sponsor:   Temple University
Withdrawn


Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A


Condition:   CMT1A
Interventions:   Drug: EllaOne;   Drug: EllaOne placebo
Sponsor:   University Hospital, Strasbourg, France
Recruiting


Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)


Condition:   Charcot-Marie-Tooth Disease Type 1A
Interventions:   Drug: PXT3003 dose 1;   Drug: PXT3003 dose 2;   Drug: placebo
Sponsor:   Pharnext SA
Active, not recruiting


Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease


Condition:   Charcot Marie Tooth Disease
Interventions:   Other: Placebo;   Drug: Mexiletine
Sponsor:   University of Rochester
Completed


Diagnosis of Carpal Tunnel Syndrome: Effectiveness of Diagnostic Tests. Clinical Trial of Accuracy


Conditions:   Carpal Tunnel Syndrome;   Compression Neuropathy, Carpal Tunnel;   Median Neuropathy, Carpal Tunnel
Intervention:   Diagnostic Test: accuracy diagnostic
Sponsor:   Federal University of São Paulo
Completed


An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients


Conditions:   Charcot Marie Tooth Disease (CMT);   Hereditary Sensory and Motor Neuropathy;   Nerve Compression Syndromes;   Tooth Diseases;   Congenital Abnormalities;   Genetic Diseases, Inborn;   Heredodegenerative Disorders, Nervous System
Intervention:  
Sponsors:   University of South Florida;   University of Rochester;   National Institute of Neurological Disorders and Stroke (NINDS)
Completed


Inherited Retinal Degenerative Disease Registry


Conditions:   Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
Intervention:  
Sponsor:   Foundation Fighting Blindness Clinical Research Institute
Recruiting


Suprascapular Neuropathy in the Setting of Rotator Cuff Tears: Results of Arthroscopic Treatment


Conditions:   Entrapment Neuropathy;   Rotator Cuff Tear
Intervention:   Procedure: Dissection of the superior transverse scapular ligament
Sponsor:   Aristotle University Of Thessaloniki
Recruiting


Chemotherapy Induced Peripheral Neuropathy. Could Physical Therapy Help Treat Symptoms?


Conditions:   Breast Cancer;   Peripheral Neuropathy, Secondary to Drugs or Chemicals
Intervention:   Other: Physical Therapy
Sponsors:   CancerCare Manitoba;   University of Manitoba
Active, not recruiting


Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)


Conditions:   Charcot Marie Tooth Disease;   Inherited Peripheral Neuropathy
Intervention:  
Sponsors:   University of Iowa;   National Institute of Neurological Disorders and Stroke (NINDS);   Charcot-Marie-Tooth Association;   Muscular Dystrophy Association;   University of Rochester;   University of South Florida
Recruiting


Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A


Conditions:   Charcot-Marie-Tooth Disease;   Hereditary Neuropathy With Liability to Pressure Palsies;   Genetic Disorders;   Tooth Disorders
Interventions:   Drug: PXT3003 Low dose;   Drug: PXT3003 Intermediate Dose;   Drug: PXT3003 High Dose;   Other: Placebo
Sponsor:   Pharnext SA
Completed


Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT


Condition:   Charcot Marie Tooth Disease
Intervention:  
Sponsors:   University of Iowa;   National Institute of Neurological Disorders and Stroke (NINDS);   Muscular Dystrophy Association;   University of Rochester;   Children's Hospital of Philadelphia;   University College London Hospitals;   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta;   Sydney Children's Hospitals Network;   Nemours Children's Clinic
Recruiting


Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others


Condition:   Charcot Marie Tooth Disease
Intervention:  
Sponsors:   University of Iowa;   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta;   Johns Hopkins University;   National Institute of Neurological Disorders and Stroke (NINDS);   King's College Hospital NHS Trust;   Nemours Children's Clinic;   Stanford University;   University of Pennsylvania;   University of Rochester;   University of Washington;   Vanderbilt University Medical Center;   Children's Hospital of Philadelphia;   Sydney Children's Hospitals Network;   Rare Diseases Clinical Research Network;   Muscular Dystrophy Association;   National Institutes of Health (NIH);   Charcot-Marie-Tooth Association;   University of Michigan;   Massachusetts General Hospital;   Cedars-Sinai Medical Center;   University of Miami;   Dubowitz Neuromuscular Centre;   University of Minnesota - Clinical and Translational Science Institute;   University of Utah;   University of Connecticut;   Universiteit Antwerpen;   University of Colorado, Denver
Recruiting


Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2


Conditions:   Charcot-Marie-Tooth Disease, Type Ia (Disorder);   HMSN
Intervention:  
Sponsors:   University of Iowa;   National Institute of Neurological Disorders and Stroke (NINDS);   Muscular Dystrophy Association;   University of Rochester;   University of Pennsylvania;   King's College Hospital NHS Trust;   Sydney Children's Hospitals Network;   Children's Hospital of Philadelphia;   University of Miami;   Johns Hopkins University;   University of Washington;   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta;   Cedars-Sinai Medical Center;   Nemours Children's Clinic;   Stanford University;   University of Michigan;   Vanderbilt University Medical Center
Recruiting


Simple Decompression Versus Anterior Transposition of the Ulnar Nerve


Conditions:   Humeral Fractures;   Ulnar Nerve Compression
Interventions:   Procedure: Simple decompression;   Procedure: anterior subcutaneous transposition
Sponsor:   St. Michael's Hospital, Toronto
Active, not recruiting


Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease


Condition:   Charcot Marie Tooth Disease
Interventions:   Drug: Coenzyme Q10;   Dietary Supplement: Coenzyme Q10
Sponsors:   Memorial Medical Center;   United States Department of Defense
Completed

Refine Your Search Advanced Search